Please sign in to follow a disease.
Sound sleep: could a simple noise improve memory in schizophrenia?
NCT ID NCT04783571
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether playing quiet sounds during a nap can help normalize brain activity and improve memory in people with schizophrenia. Researchers will compare memory and sleep patterns in 70 participants (healthy controls and schizophrenia patients) under two conditions: with and without auditory stimulation. The goal is to see if this simple, non-invasive approach can enhance sleep-related memory consolidation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- auditory stimulation (quiet sounds played during sleep)
- What this could lead to
- If it works, this could point toward a simple, non-drug way to improve memory in schizophrenia.
- What could go wrong
- This is a small, early-stage study with only 70 participants. The effects may be small or not work at all, and results may not apply to everyone with schizophrenia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2020
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: For healthy controls: * Male and female subjects * 18-50 years of age * Proficient in English For schizophrenia patients: * Male and female schizophrenia outpatients * 18-50 years of age * Proficient in English * Able to give informed consent Exclusion Criteria: * Pregnant females * Current use of psychotropic medications (healthy controls only) * A history of head injury resulting in prolonged loss of consciousness or other neurological sequelae * IQ \<85 * Neurological disorder (including seizure disorder) * Significant hearing or vision loss * Current substance abuse or dependence (nicotine abuse or dependence is not exclusionary) * Any unstable chronic medical condition that affects sleep * Diagnosed sleep disorder
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Schizophrenia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may reveal if You're taking your psychiatric medication
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug